Taysha Gene Therapies to present biodistribution data from AAV9 analysis
PremiumThe FlyTaysha Gene Therapies to present biodistribution data from AAV9 analysis
29d ago
Taysha Gene Therapies announces inducement grant under Nasdaq listing rule
Premium
The Fly
Taysha Gene Therapies announces inducement grant under Nasdaq listing rule
2M ago
Taysha Gene Therapies to present on TSHA-102 in Rett Syndrome
Premium
The Fly
Taysha Gene Therapies to present on TSHA-102 in Rett Syndrome
2M ago
TSHA Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsTSHA Upcoming Earnings Report: What to Expect?
3M ago
Taysha Gene Therapies announces inducement grant under Nasdaq listing rule
Premium
The Fly
Taysha Gene Therapies announces inducement grant under Nasdaq listing rule
5M ago
Taysha Gene Therapies price target lowered to $7 from $9 at Piper Sandler
Premium
The Fly
Taysha Gene Therapies price target lowered to $7 from $9 at Piper Sandler
5M ago
Taysha Gene Therapies proposes public offering of common stock for up to $75M
PremiumThe FlyTaysha Gene Therapies proposes public offering of common stock for up to $75M
5M ago
Neurogene negative reaction to competitor data ‘overblown,’ says William Blair
Premium
The Fly
Neurogene negative reaction to competitor data ‘overblown,’ says William Blair
5M ago
Taysha Gene Therapies Reports Promising Rett Syndrome Trial Results
Premium
Company Announcements
Taysha Gene Therapies Reports Promising Rett Syndrome Trial Results
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100